ストックスクリーナーアプリを入手
3.2811
6.92%
-0.2439
アフターアワーズ：
3.23
-0.0511
-1.56%
前日終値:
$3.525
開ける：
$3.6
24時間の取引高:
20,045
Relative Volume:
0.80
時価総額：
$4.88M
収益：
$27.40M
当期純損益:
$-17.12M
株価収益率:
-0.0307
EPS:
-106.8896
ネットキャッシュフロー:
$-24.99M
1週間 パフォーマンス:
+2.21%
1か月 パフォーマンス:
-3.27%
6か月 パフォーマンス:
-39.57%
1年 パフォーマンス:
-69.26%
1日の値動き範囲:
$3.115
$3.60
1週間の範囲:
$2.925
$3.70
52週間の値動き範囲:
$2.5211
$16.97
Dna X Inc Stock (SONM) Company Profile
Compare SONM vs MSFT, ORCL, PLTR, CRWD, FTNT
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SONM
Dna X Inc
|
3.2811 | 5.12M | 27.40M | -17.12M | -24.99M | -106.89 |
MSFT
Microsoft Corp
|
496.82 | 3.57T | 318.27B | 125.22B | 72.92B | 16.79 |
ORCL
Oracle Corp
|
145.75 | 409.23B | 67.36B | 17.31B | -23.69B | 5.8248 |
PLTR
Palantir Technologies Inc
|
169.46 | 418.04B | 5.22B | 2.29B | 2.69B | 0.8876 |
CRWD
Crowdstrike Holdings Inc
|
203.42 | 193.82B | 5.09B | -24.89M | 1.43B | -0.0471 |
FTNT
Fortinet Inc
|
154.54 | 110.64B | 7.11B | 1.95B | 2.44B | 2.5883 |
Dna X Inc Stock (SONM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2019-10-31 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2019-07-18 | 開始されました | B. Riley FBR | Buy |
| 2019-07-09 | アップグレード | National Securities | Neutral → Buy |
| 2019-06-10 | 開始されました | National Securities | Neutral |
| 2019-06-04 | 開始されました | Lake Street | Buy |
| 2019-06-04 | 開始されました | Oppenheimer | Outperform |
すべてを表示
Dna X Inc (SONM) 最新ニュース
DNA X: Q2 Earnings Snapshot - AOL.com
DNA X Q2 EPS improves to $(0.91) from $(14.15) YoY - scanx.trade
DNA X, Inc. 2Q 2026: Revenue $0 EPS $(0.92) — 10-Q Summary - TradingView
SONM: Net income surged to $5.1M as the company pivoted to crypto trading and raised $5M in new capital - TradingView
DNA X (Nasdaq: SONM) profits from phone sale while crypto platform is in the red - Stock Titan
C&F Financial Corporation Announces Quarterly Dividend - The Manila Times
Beam Global Reports Second Quarter 2026 Operating Results - The Manila Times
VVC Exploration Corporation Files Annual Financial Statements - The Manila Times
DNA X raised $5 million after its quarter ended, while its trading platform had no revenue - Stock Titan
DNA (SONM) Quarter in Focus: The Bottom-Line Figure Outpaces Its Comparison in the Latest Session; Market Reaction: The Stock Ends Down 0.60% in Latest TradingGuidance Update - vinanet.vn
12 Information Technology Stocks Moving In Monday's After-Market Session - Benzinga
Aon plc (AON) Holds Near $355.83 as Insurance Broker Consolidates Between Support and ResistanceHigh Volume Node - Vinanet
Sonim Technologies delays quarterly filing amid consolidation - TipRanks
DNA X, Inc. (SONM) delays Q2 2026 filing but projects smaller net loss - Stock Titan
SONM Q2'26 Earnings: EPS estimate is 5.22 USD - TradingView
Creative Realities, Inc. (CREX) Stock Price, News, Quote & History - finance.yahoo.com
DNA X, Inc. (SONM) raises $2.5M and targets Nasdaq equity rule compliance - Stock Titan
DNA X, Inc. (SONM) investor Lytton discloses 6.8% stake in latest 13G/A - Stock Titan
DNA X Inc. (SONM) Holds Flat at $3.56 as Range-Bound Trading PersistsChannel Breakout - vinanet.vn
Integrated DNA Technologies Scientists Set New Performance Benchmark for CRISPR Off-Target Nomination - Yahoo Finance
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Shares Slammed 36% But Getting In Cheap Might Be Difficult Regardless - 富途牛牛
DNA X, Inc. announced that it has received $5.000004 million in funding from DNA Holdings Venture, Inc. - marketscreener.com
How DNA's Double Helix Structure Was Discovered - Encyclopedia Britannica
DNA X Inc. (SONM) Slips 1.69% as Shares Test Key Support at $3.60Channel Projection - dars.gov.et
Token Talk Inc. (DNAX) stock price, news, quote and history - Yahoo Finance UK
Ginkgo Bioworks (NYSE: DNA) plans Q2 2026 results presentation and Q&A - Stock Titan
DNA X, Inc. Revenue Breakdown – NASDAQ:SONM - TradingView
VEON Ltd. (VEON) stock price, news, quote and history - Yahoo Finance UK
VEON Ltd. (VEON) Stock Price, News, Quote & History - Yahoo! Finance Canada
YD Bio and EG BioMed Conclude Successful Exhibition at BIO Asia-Taiwan 2026, Highlighting Innovations in Ophthalmology, Oncology Diagnostics, and Clinical Services - The Manila Times
Restriction-enzyme DNA fingerprinting method explained - Encyclopedia Britannica
12 Information Technology Stocks Moving In Monday's Pre-Market Session - Benzinga
DNA Sequencing Market Size to Hit USD 57.39 Billion by 2035 - Precedence Research
SAY Q2 2026 Earnings: Significant EPS Miss Raises ConcernsEstimate Uncertainty - dars.gov.et
Sonim Technologies Strengthens Capital Structure With Preferred Financing - The Globe and Mail
12 Information Technology Stocks Moving In Thursday's After-Market Session - Benzinga
DNA X, Inc. Enters Securities Purchase Agreement and Designates Series B Preferred Stock in Major 2026 Transaction - Minichart
DNA X Raises $8.1 Million Via Series B Preferred; $5.0 Million Cash, $3.1 Million Note Cancelled - TradingView
YD Bio Expands U.S. Laboratory Footprint to 46 States, Strengthening DNA-Methylation Early Cancer Detection Operations - The Manila Times
SONM Q3 2024 Earnings: Narrower-Than-Expected Loss, Stock Gains 2.14%Consensus Miss Rate - dars.gov.et
Cisco Catalyst 9300 Series Switches from Cisco Systems Inc.subscription-first campus networking p - AD HOC NEWS
Nextera Library Preparation Kit from Takara Holdings Incstreamlined NGS workflows for busy labs - AD HOC NEWS
DNA X, Inc. announced that it expects to receive $4.999998 million in funding from DNA Holdings Venture, Inc. - marketscreener.com
Applied DNA Sciences Named B2i Digital Featured Company to Share BNB-Focused Treasury Shift with Investors - The National Law Review
Study: Gen-Z and Millennials Are Aging Faster Than Their Parents—With Alarming Health Consequences - inc.com
Price to book forward of DNA X, Inc. – NASDAQ:SONM - TradingView
Price to earnings forward of DNA X, Inc. – NASDAQ:SONM - TradingView
Price to sales forward of DNA X, Inc. – NASDAQ:SONM - TradingView
12 Information Technology Stocks Moving In Friday's Intraday Session - Benzinga
WhatsApp CEO Kunal Shah said Indians don’t value time. Sanskrit scholar responds - ThePrint
Enterprise value to revenue forward of DNA X, Inc. – MUN:J6P - TradingView
Dna X Inc (SONM) 財務データ
収益
当期純利益
現金流量
EPS
1.12%
5.88%
大文字化:
|
ボリューム (24 時間):